Micin vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 53)
Micin logo

Micin

ChallengerHealthcare

Digital Health & Telemedicine (Japan)

MICIN raised 10B+ yen (~$99M) through Series C; its Curon telemedicine platform serves 5,000+ Japan clinics; digital therapeutics and clinical development tools round out a multi-pillar health tech platform.

AI VisibilityBeta
Overall Score
C53
Category Rank
#271 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
58
Perplexity
50
Gemini
57

About

MICIN is a Tokyo-based healthcare technology company founded in 2015 that operates at the intersection of telemedicine, digital therapeutics, and clinical development. Its flagship platform, Curon, enables online medical consultations — allowing patients in Japan to book appointments, receive virtual consultations, pay, and receive prescription delivery entirely online. Launched in 2016, Curon is now used by more than 5,000 clinics and hospitals across Japan.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

53
Overall Score
86
#271
Category Rank
#12
72
AI Consensus
67
stable
Trend
stable
58
ChatGPT
80
50
Perplexity
81
57
Gemini
92
53
Claude
90
47
Grok
83

Key Details

Category
Digital Health & Telemedicine (Japan)
Weight Health Platform
Tier
Challenger
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.